The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treating the untended: Real-world insights into enfortumab vedotin plus pembrolizumab for frail metastatic urothelial carcinoma patients excluded or underrepresented in clinical trials (GUARDIANS).
 
Can Aydogdu
Honoraria - Astellas Pharma; Ipsen
Travel, Accommodations, Expenses - Eisai; Ipsen; Janssen
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); AstraZeneca; Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer
 
Thomas Büttner
Honoraria - Astellas Pharma; medac pharma
Travel, Accommodations, Expenses - Ipsen; MSD
 
Marco Julius Schnabel
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Gilead Sciences; Ipsen; Ipsen (Inst); Johnson & Johnson/Janssen; Johnson & Johnson/Janssen (Inst); Medac; Merck Serono; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer; Bayer; Gilead Sciences; Ipsen; Johnson & Johnson/Janssen; MSD Oncology; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Johnson & Johnson/Janssen; Pfizer
 
Christopher Darr
Stock and Other Ownership Interests - Bayer
Honoraria - Bayer; Ipsen; Janssen; MSD
Consulting or Advisory Role - Bayer; Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Xeos medical
 
Guenter Niegisch
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Medac; Merck KGaA; MSD; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck/Pfizer; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Roche
 
Nina Holzwarth
No Relationships to Disclose
 
Anna-Lisa Volk
No Relationships to Disclose
 
Martin Hennig
No Relationships to Disclose
 
Katrin Schlack
Honoraria - AAA HealthCare; Amgen (Inst); Astellas Pharma; AstraZeneca; Bayer Germany; Eisai Germany; Fosanis; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pfizer
Consulting or Advisory Role - Apogepha; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen; Pfizer
 
Subhajit Mandal
No Relationships to Disclose
 
Julia Heinzelbecker
No Relationships to Disclose
 
Frederik Wessels
Honoraria - Bayer Germany; Ipsen; Johnson & Johnson/Janssen; Medac; MSD Oncology
Consulting or Advisory Role - Adon Health; Astellas Pharma; AstraZeneca; Johnson & Johnson/Janssen
 
Joschka Heil
No Relationships to Disclose
 
Philipp Schmucker
No Relationships to Disclose
 
Pia Paffenholz
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Ipsen; Janssen; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Friedemann Zengerling
Honoraria - Amgen; Apogepha; Astellas Pharma; Bayer/Vital; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Apogepha; Astellas Pharma; AstraZeneca; Bayer Health; Bristol-Myers Squibb; IPSEN; Janssen; Merck; Merck Sharp & Dohme; Novartis; Onkowissen; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer Health; IPSEN; Janssen; Pfizer
 
Eva Erne
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Merck; Pfizer
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - Amgen; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Genmab; MSD
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Roche; Telix Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; Pfizer; Recordati; Synthekine
Research Funding - Amgen (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck Serono; Pfizer
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer
 
GUARDIANS
No Relationships to Disclose